journal
MENU ▼
Read by QxMD icon Read
search

European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care

journal
https://www.readbyqxmd.com/read/30511340/income-distribution-and-health-can-polarization-explain-health-outcomes-better-than-inequality
#1
Ying Yao, Guanghua Wan, Dongfang Meng
Utilizing data from the China Health and Nutrition Survey (CHNS) from 1991 to 2011, we aim to analyze the effects of income distribution on two risks for chronic diseases: body mass index (BMI) and blood pressure. Unlike the previous studies, we consider two different kinds of indicators of income distribution: inequality and polarization. Different from relative inequality indicators such as the Gini index, which measure income gaps only, the recently developed polarization indicator captures group clustering and social alienation, in addition to income gaps...
December 4, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/30467690/co-ordination-of-health-care-the-case-of-hospital-emergency-admissions
#2
M Kamrul Islam, Egil Kjerstad
The recognition that chronic care delivery is suboptimal has led many health authorities around the world to redesign it. In Norway, the Department of Health and Care Services implemented the Coordination Reform in January 2012. One policy instrument was to build emergency bed capacity (EBC) as an integrated part of primary care service provided by municipalities. The explicit aim was to reduce the rate of avoidable admissions to state-owned hospitals. Using five different sources of register data and a quasi-experimental framework-the "difference-in-differences" regression approach-we estimated the association between changes in EBC on changes in aggregate emergency hospital admissions for eight ambulatory care sensitive conditions (ACSC)...
November 22, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/30382484/denosumab-versus-bisphosphonates-for-the-treatment-of-bone-metastases-from-solid-tumors-a-systematic-review
#3
Jessica Y Matuoka, James G Kahn, Silvia R Secoli
BACKGROUND: Bone metastases are highly prevalent in breast, prostate, lung and colon cancers. Their symptoms negatively affect quality of life and functionality and optimal management can mitigate these problems. There are two different targeted agents to treat them: bisphosphonates (pamidronate and zoledronic acid) and the monoclonal antibody denosumab. Estimates of cost-effectiveness are still mixed. OBJECTIVE: To conduct a systematic review of economic studies that compares these two options...
October 31, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/30377849/including-intangible-costs-into-the-cost-of-illness-approach-a-method-refinement-illustrated-based-on-the-pm-2-5-economic-burden-in-china
#4
Bangzhu Zhu, Runzhi Pang, Julien Chevallier, Yi-Ming Wei, Dinh-Tri Vo
The concentrations of particulate matter with aerodynamic diameters less than 2.5 µm (PM2.5 ) and 10 µm (PM10 ) is a widespread concern and has been demonstrated for 103 countries. During the past few years, the exposure-response function (ERf) has been widely used to estimate the health effects of air pollution. However, past studies are either based on the cost-of-illness or the willingness-to-pay approach, and therefore, either do not cover intangible costs or costs due to the absence of work. To address this limitation, a hybrid health effect and economic loss model is developed in this study...
October 30, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/30374630/stratified-treatment-recommendation-or-one-size-fits-all-a-health-economic-insight-based-on-graphical-exploration
#5
Qi Cao, Erik Buskens, Hans L Hillege, Tiny Jaarsma, Maarten Postma, Douwe Postmus
OBJECTIVES: We sought to explore to what extent the use of Subpopulation Treatment Effect Pattern Plot (STEPP) may help to identify efficient treatment allocation strategy. METHODS: The analysis was based on data from the COACH study, in which 1023 patients with heart failure were randomly assigned to three treatments: care-as-usual, basic support, and intensive support. First, using predicted 18-month mortality risk as the stratification basis, a suitable strategy for assigning different treatments to different risk groups of patients was developed...
October 29, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/30357489/do-political-factors-influence-public-health-expenditures-evidence-pre-and-post-great-recession
#6
Héctor Bellido, Lorena Olmos, Juan Antonio Román-Aso
This paper analyses whether government ideology and other political- and electoral-related factors influence country-level public healthcare expenditures, focussing on the impact of the Great Recession on that relationship. We test this hypothesis for the OECD countries in 1970-2016. Our results reveal the presence of a partisan effect, left-wing governments being more likely to raise public expenditures in the health sector. We also find that coalitions increase these expenditures, whilst minority governments and those with a high presence in the lower house decrease them...
October 24, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/30276497/alcohol-quantity-and-quality-price-elasticities-quantile-regression-estimates
#7
Robert Pryce, Bruce Hollingsworth, Ian Walker
Many people drink more than the recommended level of alcohol, with some drinking substantially more. There is evidence that suggests that this leads to large health and social costs, and price is often proposed as a tool for reducing consumption. This paper uses quantile regression methods to estimate the differential price (and income) elasticities across the drinking distribution. This is also done for on-premise (pubs, bars and clubs) and off-premise (supermarkets and shops) alcohol separately. In addition, we examine the extent to which drinkers respond to price changes by varying the 'quality' of the alcohol that they consume...
October 1, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/30229376/advanced-therapy-medicinal-products-and-health-technology-assessment-principles-and-practices-for-value-based-and-sustainable-healthcare
#8
Bengt Jönsson, Grace Hampson, Jonathan Michaels, Adrian Towse, J-Matthias Graf von der Schulenburg, Olivier Wong
BACKGROUND: Advanced therapy medicinal products (ATMPs) are beginning to reach European markets, and questions are being asked about their value for patients and how healthcare systems should pay for them. OBJECTIVES: To identify and discuss potential challenges of ATMPs in view of current health technology assessment (HTA) methodology-specifically economic evaluation methods-in Europe as it relates to ATMPs, and to suggest potential solutions to these challenges...
September 18, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/30229375/cost-effectiveness-of-controlling-gestational-diabetes-mellitus-a-systematic-review
#9
Najmiatul Fitria, Antoinette D I van Asselt, Maarten J Postma
OBJECTIVE: Timely screening for hyperglycaemia in pregnancy using a simple glucose test enhances early detection and control of gestational diabetes mellitus (GDM). The aim of this study was to provide an overview of the evidence on the cost-effectiveness of identification and/or treatment of GDM. METHODS: We conducted a systematic review using three electronic databases (PubMed, EMBASE, and Cochrane) of cost-effectiveness studies of GDM screening and treatment published during 2000-2017...
September 18, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/30229374/a-qaly-loss-is-a-qaly-loss-is-a-qaly-loss-a-note-on-independence-of-loss-aversion-from-health-states
#10
Stefan A Lipman, Werner B F Brouwer, Arthur E Attema
Evidence has accumulated documenting loss aversion for monetary and, recently, for health outcomes-meaning that, generally, losses carry more weight than equally sized gains. In the conventional Quality-Adjusted Life Year (QALY) models, which comprise utility for quality and length of life, loss aversion is not taken into account. When measuring elements of the QALY model, commonly, the (implicit) assumption is that utility for length and quality of life are independent. First attempts to quantify loss aversion for QALYs typically measured loss aversion in the context of life duration, keeping quality of life constant (or vice versa)...
September 18, 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29725786/health-inequality-indices-and-exogenous-risk-factors-an-illustration-on-luxembourgish-workers
#11
Stéphane Mussard, Maria Noel Pi Alperin, Véronique Thireau
This paper proposes an aggregable family of multidimensional concentration indices which is characterized in order to be consistent with a property of exogenous risk factors, i.e. health risks for which agents are not responsible for. It is shown that those indices are of interest when individuals face different risk factors, whereas traditional indices fail to deal with heterogeneous agents. In this respect, necessary and suficient conditions are stated in order to rank two health distributions thanks to the generalized concentration curves...
December 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29696460/tackling-the-chronic-disease-burden-are-there-co-benefits-from-climate-policy-measures
#12
Désirée Vandenberghe, Johan Albrecht
Each year, non-communicable diseases (NCDs) kill 40 million people worldwide and impose an estimated economic burden of $600 billion. Without effective policymaking, NCDs will continue to undermine health and economic systems globally. We propose that climate policy measures-such as carbon pricing-can yield significant health-related co-benefits aside from their intended greenhouse gas emission reduction. We simulate three carbon tax scenarios in the energy and food sector in Belgium and assess the resulting health-related co-benefits...
December 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29696459/economic-evaluation-of-zepatier-for-the-management-of-hcv-in-the-italian-scenario
#13
F R Rolli, M Ruggeri, F Kheiraoui, C Drago, M Basile, C Favaretti, A Cicchetti
BACKGROUND: Hepatitis C virus (HCV) is a major health issue worldwide. New generation of direct-active antiviral medications is an epoch-making turning point in the management of HCV infections. OBJECTIVE: Conducing a cost-effectiveness analysis comparing the combination of elbasvir/grazoprevir and sofosbuvir + pegylated interferon/ribavirin for the management of all HCV patients (even those in the initial stages of fibrosis). METHODS: A Markov model was built on the natural history of the disease to assess the efficacy of the alternatives...
December 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29687269/people-s-perception-and-cost-effectiveness-of-home-confinement-during-an-influenza-pandemic-evidence-from-the-french-case
#14
Caroline Orset
In France, home confinement is not a common preventive measure against an influenza pandemic, although it is used around the world. Based on a stated method approach, we analyze the attitude that the French would adopt if this measure were put in place. Next, we propose a cost-benefit analysis to discuss the cost-effectiveness of this measure. We find that over three-quarters of respondents report complying with home confinement. Their choice depends on their individual characteristics, the interaction they may have with an infected person and home confinement conditions, but not their experience with preventive measures...
December 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29687268/cost-effectiveness-of-enhancing-a-quit-and-win-smoking-cessation-program-for-college-students
#15
Jonah Popp, John A Nyman, Xianghua Luo, Jill Bengtson, Katherine Lust, Lawrence An, Jasjit S Ahluwalia, Janet L Thomas
OBJECTIVES: We conducted a cost-effectiveness analysis and model-based cost-utility and cost-benefit analysis of increased dosage (3 vs. 1 consecutive contests) and enhanced content (supplemental smoking-cessation counseling) of the Quit-and-Win contest using data from a randomized control trial enrolling college students in the US. METHODS: For the cost-utility and cost-benefit analyses, we used a microsimulation model of the life course of current and former smokers to translate the distribution of the duration of continuous abstinence among each treatment arm's participants observed at the end of the trial (N = 1217) into expected quality-adjusted life-years (QALYs) and costs and an incremental net monetary benefit (INMB)...
December 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29680926/the-economic-impact-of-multiple-sclerosis-to-the-patients-and-their-families-in-norway
#16
B Svendsen, N Grytten, L Bø, H Aarseth, T Smedal, K-M Myhr
BACKGROUND: Multiple sclerosis (MS) imposes high economic costs on society, but the patients and their families have to bear some of these costs. OBJECTIVE: We aimed to estimate the magnitude of these economic costs in Norway. METHOD: We collected data through a postal questionnaire survey targeting 922 MS patients in Hordaland County, western Norway, in 2013-2014; 546 agreed to participate and were included. The questionnaire included clinical and demographic characteristics, volume and cost of MS-related resource use, work participation, income, government financial support, and disability status...
December 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29671144/examining-unpriced-risk-heterogeneity-in-the-dutch-health-insurance-market
#17
A A Withagen-Koster, R C van Kleef, F Eijkenaar
A major challenge in regulated health insurance markets is to mitigate risk selection potential. Risk selection can occur in the presence of unpriced risk heterogeneity, which refers to predictable variation in health care spending not reflected in either premiums by insurers or risk equalization payments. This paper examines unpriced risk heterogeneity within risk groups distinguished by the sophisticated Dutch risk equalization model of 2016. Our strategy is to combine the administrative dataset used for estimation of the risk equalization model (n = 16...
December 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29671142/what-should-we-know-about-the-person-behind-a-tto
#18
EDITORIAL
Floortje van Nooten, Jan Busschbach, Michel van Agthoven, Job van Exel, Werner Brouwer
No abstract text is available yet for this article.
December 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29626266/preferences-for-home-and-community-based-long-term-care-services-in-germany-a-discrete-choice-experiment
#19
T Lehnert, O H Günther, A Hajek, S G Riedel-Heller, H H König
BACKGROUND: Most people prefer to "age in place" and to remain in their homes for as long as possible even in case they require long-term care. While informal care is projected to decrease in Germany, the use of home- and community-based services (HCBS) can be expected to increase in the future. Preference-based data on aspects of HCBS is needed to optimize person-centered care. OBJECTIVE: To investigate preferences for home- and community-based long-term care services packages...
December 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://www.readbyqxmd.com/read/29574666/impact-of-increasing-treatment-rates-on-cost-effectiveness-of-subcutaneous-immunotherapy-scit-in-respiratory-allergy-a-decision-analytic-modelling-approach
#20
Ann-Kathrin Richter, Ludger Klimek, Hans F Merk, Norbert Mülleneisen, Harald Renz, Wolfgang Wehrmann, Thomas Werfel, Eckard Hamelmann, Uwe Siebert, Gaby Sroczynski, Jürgen Wasem, Janine Biermann-Stallwitz
BACKGROUND: Specific immunotherapy is the only causal treatment in respiratory allergy. Due to high treatment cost and possible severe side effects subcutaneous immunotherapy (SCIT) is not indicated in all patients. Nevertheless, reported treatment rates seem to be low. This study aims to analyze the effects of increasing treatment rates of SCIT in respiratory allergy in terms of costs and quality-adjusted life years (QALYs). METHODS: A state-transition Markov model simulates the course of disease of patients with allergic rhinitis, allergic asthma and both diseases over 10 years including a symptom-free state and death...
December 2018: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
journal
journal
39984
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"